Speaker: Sibylle Loibl

Professor Sibylle Loibl - 2023 Breast Cancer Trials Annual Scientific Meeting

Breast Cancer Trials

Maintenance w/ ET + ribociclib after 1L chemotherapy in HR+/HER2- metastatic breast cancer

Future of breast cancer care: HER2 therapies in earlier settings & de-escalation

Remaining questions on the use of frontline CDK4/6 inhibitors + endocrine therapy

PENELOPE-B: palbociclib with endocrine therapy in HR+, HER2-negative breast cancer

Long-term survival of the Phase II GeparOLA study

Composite biomarkers predictive of palbociclib + endocrine treatment benefit in early breast cancer

Carboplatin’s future in breast cancer treatment

Trastuzumab deruxtecan in metastatic HER2+ breast cancer

CDK4/6 inhibitors: a hot topic in breast cancer treatment

Changes in tumour biomarkers after neoadjuvant chemotherapy in breast cancer

Key takeaways from SABCS 2022

DEBATE: "RxPONDER: Was it all OFS?" Con

San Antonio Breast Cancer Symposium

Exciting updates from SABCS 2020

Is carboplatin an effective addition in the treatment of breast cancer?

Sharing knowledge on treating cancer during pregnancy

Pregnancy & Medicine Initiative

How can international collaboration benefit young researchers?

BIG against breast cancer

What advice would you give to a pregnant mom with cancer?

Pregnancy & Medicine Initiative

Jahrestreffen 2022: Begrüßung

German Breast Group